In cystic fibrosis, those carrying functional variants of mannose-binding lectin (MBL) have worse pulmonary outcomes,177 and replacement MBL therapy has been reported in MBL-deficient cystic fibrosis patients.178. Here, MBL2 is linked to cystic fibrosis.